MPC vs PMCB · P/E 16, rev $138.86B vs $8.6M cap
Marathon Petroleum Corp (MPC) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the MPC and PMCB stock pages for the full models.
Not investment advice.